210 related articles for article (PubMed ID: 36324652)
21. Gray matter volume abnormalities and clinical correlates in OCD with exclusive washing dimension.
Kodancha PG; Shivakumar V; Jose D; Venkatasubramanian G; Reddy YCJ; Narayanaswamy JC
Asian J Psychiatr; 2020 Dec; 54():102343. PubMed ID: 32795957
[TBL] [Abstract][Full Text] [Related]
22. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.
Szeszko PR; Christian C; Macmaster F; Lencz T; Mirza Y; Taormina SP; Easter P; Rose M; Michalopoulou GA; Rosenberg DR
Am J Psychiatry; 2008 Oct; 165(10):1299-307. PubMed ID: 18413702
[TBL] [Abstract][Full Text] [Related]
23. Neural correlates of obsessive-compulsive related dysfunctional beliefs.
Alonso P; Orbegozo A; Pujol J; López-Solà C; Fullana MÀ; Segalàs C; Real E; Subirà M; Martínez-Zalacaín I; Menchón JM; Harrison BJ; Cardoner N; Soriano-Mas C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():25-32. PubMed ID: 23911440
[TBL] [Abstract][Full Text] [Related]
24. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder.
Zarei M; Mataix-Cols D; Heyman I; Hough M; Doherty J; Burge L; Winmill L; Nijhawan S; Matthews PM; James A
Biol Psychiatry; 2011 Dec; 70(11):1083-90. PubMed ID: 21903200
[TBL] [Abstract][Full Text] [Related]
25. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders.
Radua J; van den Heuvel OA; Surguladze S; Mataix-Cols D
Arch Gen Psychiatry; 2010 Jul; 67(7):701-11. PubMed ID: 20603451
[TBL] [Abstract][Full Text] [Related]
26. Brain structural abnormalities in Doberman pinschers with canine compulsive disorder.
Ogata N; Gillis TE; Liu X; Cunningham SM; Lowen SB; Adams BL; Sutherland-Smith J; Mintzopoulos D; Janes AC; Dodman NH; Kaufman MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():1-6. PubMed ID: 23590875
[TBL] [Abstract][Full Text] [Related]
27. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study.
Gilbert AR; Mataix-Cols D; Almeida JR; Lawrence N; Nutche J; Diwadkar V; Keshavan MS; Phillips ML
J Affect Disord; 2008 Jul; 109(1-2):117-26. PubMed ID: 18342953
[TBL] [Abstract][Full Text] [Related]
28. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
[TBL] [Abstract][Full Text] [Related]
29. Gray Matter Volume Differences in Impulse Control and Addictive Disorders-An Evidence From a Sample of Heterosexual Males.
Draps M; Sescousse G; Potenza MN; Marchewka A; Duda A; Lew-Starowicz M; Kopera M; Jakubczyk A; Wojnar M; Gola M
J Sex Med; 2020 Sep; 17(9):1761-1769. PubMed ID: 32690426
[TBL] [Abstract][Full Text] [Related]
30. Cerebral white matter volume changes in patients with obsessive-compulsive disorder: Voxel-based morphometry.
Park SE; Jeong GW
Psychiatry Clin Neurosci; 2015 Nov; 69(11):717-23. PubMed ID: 25966931
[TBL] [Abstract][Full Text] [Related]
31. Shared gray matter reductions across alcohol use disorder and posttraumatic stress disorder in the anterior cingulate cortex: A dual meta-analysis.
Klaming R; Harlé KM; Infante MA; Bomyea J; Kim C; Spadoni AD
Neurobiol Stress; 2019 Feb; 10():100132. PubMed ID: 30627600
[TBL] [Abstract][Full Text] [Related]
32. Brain microstructural changes and cognitive correlates in patients with pure obsessive compulsive disorder.
Spalletta G; Piras F; Fagioli S; Caltagirone C; Piras F
Brain Behav; 2014 Mar; 4(2):261-77. PubMed ID: 24683518
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of brain volume changes in obsessive-compulsive disorder.
Rotge JY; Guehl D; Dilharreguy B; Tignol J; Bioulac B; Allard M; Burbaud P; Aouizerate B
Biol Psychiatry; 2009 Jan; 65(1):75-83. PubMed ID: 18718575
[TBL] [Abstract][Full Text] [Related]
34. Caudate gray matter volume in obsessive-compulsive disorder is influenced by adverse childhood experiences and ongoing drug treatment.
Benedetti F; Poletti S; Radaelli D; Pozzi E; Giacosa C; Ruffini C; Falini A; Smeraldi E
J Clin Psychopharmacol; 2012 Aug; 32(4):544-7. PubMed ID: 22722505
[TBL] [Abstract][Full Text] [Related]
35. Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis.
Rotge JY; Langbour N; Guehl D; Bioulac B; Jaafari N; Allard M; Aouizerate B; Burbaud P
Neuropsychopharmacology; 2010 Feb; 35(3):686-91. PubMed ID: 19890260
[TBL] [Abstract][Full Text] [Related]
36. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
[TBL] [Abstract][Full Text] [Related]
37. Relationship between symptom dimensions and brain morphology in obsessive-compulsive disorder.
Hirose M; Hirano Y; Nemoto K; Sutoh C; Asano K; Miyata H; Matsumoto J; Nakazato M; Matsumoto K; Masuda Y; Iyo M; Shimizu E; Nakagawa A
Brain Imaging Behav; 2017 Oct; 11(5):1326-1333. PubMed ID: 27730476
[TBL] [Abstract][Full Text] [Related]
38. Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry.
Hashimoto N; Nakaaki S; Kawaguchi A; Sato J; Kasai H; Nakamae T; Narumoto J; Miyata J; Furukawa TA; Mimura M
Neuropsychiatr Dis Treat; 2014; 10():1987-96. PubMed ID: 25349476
[TBL] [Abstract][Full Text] [Related]
39. Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis.
Zhang M; Gao X; Yang Z; Wen M; Huang H; Zheng R; Wang W; Wei Y; Cheng J; Han S; Zhang Y
Psychopharmacology (Berl); 2021 Sep; 238(9):2365-2379. PubMed ID: 34313804
[TBL] [Abstract][Full Text] [Related]
40. Anterior insular volume is larger in patients with obsessive-compulsive disorder.
Nishida S; Narumoto J; Sakai Y; Matsuoka T; Nakamae T; Yamada K; Nishimura T; Fukui K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):997-1001. PubMed ID: 21303681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
